Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells

Donghai Xiong; Zheng Yin; Mofei Huang; Yian Wang; Micael Hardy; Balaraman Kalyanaraman; Stephen T. Wong; Ming You

doi:10.1002/cac2.12500

Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells

Donghai Xiong, Zheng Yin, Mofei Huang, Yian Wang, Micael Hardy, Balaraman Kalyanaraman, Stephen T. Wong, Ming You

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Journal	Cancer Communications
DOIs	https://doi.org/10.1002/cac2.12500
State	Published - Nov 6 2023

Access to Document

10.1002/cac2.12500

Cite this

@article{dd702f8878b14fdd94d24b9e2207fdb0,

title = "Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells",

author = "Donghai Xiong and Zheng Yin and Mofei Huang and Yian Wang and Micael Hardy and Balaraman Kalyanaraman and Wong, {Stephen T.} and Ming You",

note = "Funding Information: This research was supported by National Institutes of Health (NIH): R01CA223804, R01CA232433, R01CA205633, and R01CA280746. Funding Information: This work was supported by grants from National Institutes of Health (R01CA223804, R01CA232433, R01CA205633, and R01CA280746). This work was supported in part by the International Research Project SuperO2 from CNRS, France.",

year = "2023",

month = nov,

day = "6",

doi = "10.1002/cac2.12500",

language = "English (US)",

journal = "Cancer Communications",

issn = "2523-3548",

publisher = "John Wiley & Sons Inc.",

}

TY - JOUR

T1 - Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells

AU - Xiong, Donghai

AU - Yin, Zheng

AU - Huang, Mofei

AU - Wang, Yian

AU - Hardy, Micael

AU - Kalyanaraman, Balaraman

AU - Wong, Stephen T.

AU - You, Ming

N1 - Funding Information: This research was supported by National Institutes of Health (NIH): R01CA223804, R01CA232433, R01CA205633, and R01CA280746. Funding Information: This work was supported by grants from National Institutes of Health (R01CA223804, R01CA232433, R01CA205633, and R01CA280746). This work was supported in part by the International Research Project SuperO2 from CNRS, France.

PY - 2023/11/6

Y1 - 2023/11/6

UR - http://www.scopus.com/inward/record.url?scp=85176136734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85176136734&partnerID=8YFLogxK

U2 - 10.1002/cac2.12500

DO - 10.1002/cac2.12500

M3 - Letter

C2 - 37930151

SN - 2523-3548

JO - Cancer Communications

JF - Cancer Communications

ER -

Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells

Access to Document

Other files and links

Cite this